Status:
WITHDRAWN
Peripheral Analgesia in Painful Diabetic Neuropathy
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Diabetic Neuropathy Peripheral
Neuropathic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic obliterative arteriopathy of the inferior limbs is a frequent condition observed in diabetics. The later stages induce pain at rest and trophic disorders (ulcer, gangrene) that lead to chronic...
Detailed Description
Patients are allocated in two groups regarding : * their eligibility to analgesic treatment using continuous peripheral nerve blocks * the unability of usual pain management to reduce their pain (pai...
Eligibility Criteria
Inclusion
- Hospitalized patient
- Diabetics with chronic obliterative arteriopathy of the inferior limbs
- Permanent limb ischaemia with a TcPO2 of the front-foot of at least 10 mmHg under atmospheric conditions
- Lack of surgical revascularization
- No contraindication to hyperbaric therapy
- Signed informed consent
Exclusion
- Contraindication to ropivacaine
- Conditions that could alter hyperbaric measurements (anemia \< 8 g/dl, cardiac or respiratory insufficiency)
- patients with planned limb amputation
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03354806
Start Date
June 1 2018
End Date
December 1 2019
Last Update
March 7 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.